Adicet Bio Inc (ACET)
1.93
-0.10
(-4.69%)
USD |
NASDAQ |
Apr 19, 12:06
Adicet Bio Cash and Short Term Investments (Quarterly): 159.71M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 159.71M |
| September 30, 2023 | 183.26M |
| June 30, 2023 | 205.46M |
| March 31, 2023 | 231.64M |
| December 31, 2022 | 257.66M |
| September 30, 2022 | 282.68M |
| June 30, 2022 | 260.64M |
| March 31, 2022 | 277.88M |
| Date | Value |
|---|---|
| December 31, 2021 | 277.54M |
| September 30, 2021 | 192.23M |
| June 30, 2021 | 208.73M |
| March 31, 2021 | 223.42M |
| December 31, 2020 | 94.61M |
| September 30, 2020 | 108.12M |
| December 31, 2019 | 62.40M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
62.40M
Minimum
Dec 2019
282.68M
Maximum
Sep 2022
201.73M
Average
208.73M
Median
Jun 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Sagimet Biosciences Inc | 94.90M |
| Catalyst Pharmaceuticals Inc | 137.64M |
| Codexis Inc | 65.12M |
| Annexon Inc | 259.72M |
| Inhibrx Inc | 277.92M |